Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists

Journal of Biological Chemistry

Volumn 274, Issue 50, 1999, Pages 35469-35474

  Albert, Paul R ^a,c   Sajedi, Naghmeh ^a   Lemonde, Sylvie ^a   Ghahremani, Mohammad H ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BUSPIRONE; CYCLIC AMP; FLESINOXAN; PERTUSSIS TOXIN; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR; SPIPERONE;

ANXIETY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CELL; LIGAND BINDING; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

EID: 0033544910     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.274.50.35469     Document Type: Article

References (51)

1. Blier, P., and de Montigny, C. (1994) Trends Pharmacol. Sci. 15, 220-226
2. Peroutka, S. J. (1993) J. Neurochem. 60, 408-416
3. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., and Humphrey, P. P. (1994) Pharmacol. Rev. 48, 157-203
4. Mongeau, R., Blier, P., and de Montigny, C. (1997) Brain Res. Rev. 23, 145-195
5. Charney, D. S., Krystal, J. H., Delgado, P. L., and Heninger, G. R. (1990) Annu. Rev. Med. 41, 437-446
6. Artigas, F., Romero, L., Demontigny, C., and Blier, P. (1996) Trends Neurosci. 19, 378-383
7. Albert, P. R., Lembo, P., Storring, J. M., Charest, A., and Saucier, C. (1996) Neuropsychopharmacology 14, 19-25
8. Parks, C. L., Robinson, P. S., Sibille, E., Shenk, T., and Toth, M. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 10734-10739
9. Ramboz, S., Oosting, R., Amara, D. A., Kung, H. F., Blier, P., Mendelsohn, M., Mann, J. J., Brunner, D., and Hen, R. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 14476-14481
10. Heisler, L. K., Chu, H. M., Brennan, T. J., Danao, J. A., Bajwa, P., Parsons, L. H., and Tecott, L. H. (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 15049-15054
11. Cadogan, A. K., Kendall, D. A., and Marsden, C. A. (1994) J. Neurochem. 62, 1816-1821
12. Markstein, R., Hoyer, D., and Engel, G. (1986) Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 335-341
13. Shenker, A., Maayani, S., Weinstein, H., and Green, J. P. (1987) Mol. Pharmacol. 31, 357-367
14. Andrade, R. (1993) Neuron 10, 83-88
15. Baker, L. P., Nielson, M. D., Impey, S., Hacker, B. M., Poser, S. W., Chan, M. Y. M., and Storm, D. R. (1999) J. Neurosci. 19, 180-192
16. Federman, A. D., Conklin, B. R., Schrader, K. A., Reed, R. R., and Bourne, H. R. (1992) Nature 356, 159-161
17. Sunahara, R. K., Dessauer, C. W., and Gilman, A. G, (1996) Annu. Rev. Pharmacol. Toxicol. 36, 461-480
18. Liu, Y. F., Ghahremani, M. H., Rasenick, M. M., Jakobs, K. H., and Albert, P. R. (1999) J. Biol. Chem. 274, 16444-16450
19. Jin, H., Oksenberg, D., Ashkenazi, A., Peroutka, S. J., Duncan, A. M., Rozmahel, R., Yang, Y., Mengod, G., Palacios, J. M., and O'Dowd, B. F. (1992) J. Biol. Chem. 267, 5735-5738
20. Liu, Y. F., Civelli, O., Zhou, Q. Y., and Albert, P. R. (1992) Mol. Endocrinol. 6, 1815-1824
21. Ghahremani, M. H., Cheng, P., Lembo, P. M. C., and Albert, P. R. (1999) J. Biol. Chem. 274, 9238-9245
22. Lembo, P. M., Ghahremani, M. H., and Albert, P. R. (1999) Mol. Endocrinol. 13, 138-147
23. Lembo, P. M., Ghahremani, M. H., Morris, S. J., and Albert, P. R. (1997) Mol. Pharmacol. 52, 164-171
24. Albert, P. R., Zhou, Q. Y., Van Tol, H. H., Bunzow, J. R., and Civelli, O. (1990) J. Biol. Chem. 265, 5825-5832
25. Chan, J. S., Chiu, T. T., and Wong, Y. H. (1995) J. Neurochem. 65, 2682-2689
26. Tsu, R. C., Chan, J. S., and Wong, Y. H. (1995) J. Neurochem. 64, 2700-2707
27. Tsu, R. C., Allen, R. A., and Wong, Y. H. (1995) Mol. Pharmacol. 47, 835-841
28. Barr, A. J., Brass, L. F., and Manning, D. R. (1997) J. Biol. Chem. 272, 2223-2229
29. Newman-Tancredi, A., Conte, C., Chaput, C., Spedding, M., and Millan, M. J. (1997) Br J. Pharmacol. 120, 737-739
30. Newman-Tancredi, A., Conte, C., Chaput, C., Verriele, L., and Millan, M. J. (1997) Neuropharmacol. 36, 451-459
31. Bertin, B., Freissmuth, M., Breyer, R. M., Schutz, W., Strosberg, A. D., and Marullo, S. (1992) J. Biol. Chem. 267, 8200-8206
32. Lembo, P. M., and Albert, P. R. (1995) Mol. Pharmacol. 48, 1024-1029
33. Albert, P. R., Morris, S. J., Ghahremani, M. H., Storring, J. M., and Lembo, P. M. (1998) Ann. N. Y. Acad. Sci. 861, 146-161
34. Butkerait, P., Zheng, Y., Hallak, H., Graham, T. E., Miller, H. A., Burris, K. D., Molinoff, P. B., and Manning, D. R. (1995) J. Biol. Chem. 270, 18691-18699
35. Mulheron, J. G., Casanas, S. J., Arthur, J. M., Garnovskaya, M. N., Gettys, T. W., and Raymond, J. R. (1994) J. Biol Chem. 269, 12954-12962
36. Raymond, J. R., Olsen, C. L., and Gettys, T. W. (1993) Biochemistry 32, 11064-11073
37. Koch, W. J., Hawes, B. E., Inglese, J., Luttrell, L. M., and Lefkowitz, R. J. (1994) J. Biol. Chem. 269, 6193-6197
38. Touhara, K., Koch, W. J., Hawes, B. E., and Lefkowitz, R. J. (1995) J. Biol. Chem. 270, 17000-17005
39. Rudolph, U., Spicher, K., and Birnbaumer, L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 3209-3214
40. Schoeffter, P., Bobirnac, I., Boddeke, E., and Hoyer, D. (1997) Neuropharmacol. 36, 429-437
41. Fletcher, A., Cliffe, I. A., and Dourish, C. T. (1993) Trends Pharmacol. Sci. 14, 41-48
42. Hoyer, D., and Boddeke, H. W. (1993) Trends Pharmacol. Sci. 14, 270-275
43. Pauwels, P. J., Van Gompel, P., and Leysen, J. E. (1993) Biochem. Pharmacol. 45, 375-383
44. Stanhope, K. J., and Dourish, C. T. (1996) Psychopharmacology 128, 293-303
45. Taylor, D. P. (1990) Ann. N. Y, Acad. Sci. 600, 545-557
46. Lucki, I. (1996) J. Clin. Psychiat. 57, 5-10
47. Leff, P., Scaramellini, C., Law, C., and McKechnie, K. (1997) Trends Pharmacol. Sci. 18, 355-362
48. Kenakin, T. (1995) Trends Pharmacol. Sci. 16, 232-238
49. Kenakin, T. (1997) Trends Pharmacol. Sci. 18, 416-417
50. Dunlop, J., Zhang, Y., Smith, D. L., and Schlechter, L. E. (1998) J. Pharmacol. Toxicol. Methods 40, 47-55
51. Olivier, B., Soudijn, W., and van Wijngaarden, I. (1999) Prog. Drug Res. 52, 103-165